CHMP backs Ipsen drug for childhood brain cancer
Ipsen's Ojemda is on course to become the first targeted medicine in the EU for some children with a form of brain cancer known as low-grade glioma.
New biotech Atrium born out of Novartis/Avidity marriage
Atrium Therapeutics has launched with $270m in funding and two preclinical siRNA candidates for rare genetic cardiomyopathies.
NHS "isn't delivering equitable care for rare diseases"
A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Moderna closes on EU approval for combined flu/COVID jab
Moderna's combined vaccine for both flu and COVID-19 has been recommended for approval in the EU, after being knocked back in the US.
Boehringer gets FDA's second 'national priority' approval
Boehringer Ingelheim's lung cancer drug Hernexeos has become the second medicine approved after an FDA national priority review.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
7th Dermatology Drug Development Summit Europe
The Summit is a premier three-day industry event designed for senior leaders, clinical scientists, regulatory experts and commercial strategists
The PM Society Launches Pharmony to Support More Effective P...
The Pharmaceutical Marketing Society (PM Society) today announces the launch of Pharmony
EVERSANA Names Monica Avram Executive Vice President and Chi...
As chief legal officer and a member of the Executive Leadership Team, Monica Avram leads EVERSANA's global Legal and Compliance function.
Emerging Trends in Personalised Medicine at PHARMAP 2026
The Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual event that fosters networking and knowledge-sharing among professionals
Book your tickets and join the PM Society for the 40th PM Aw...
Tickets are on sale for the 40th anniversary of the PM Awards